Jump to navigation
Unless damaging provisions are removed before negotiations are finalized, the TPP agreement is on track to become the most harmful trade pact ever for access to medicines in developing countries.
Over the last few years, new vaccines to fight an increased range of childhood diseases have come to market.
Vaccinating with new vaccines should save many more lives, but high prices could prevent this from happening.
Immunization is one of the most effective ways of saving young lives, yet every year one in five children born—22 million—is left without this basic protection from disease.
Read MSF's submission to the US trade representative on the 2012 Special 301 review process, which affects accessibility of medicines and important diagnostic tools.
Read Novartis's statements on its generic medicines court case, and learn why they're wrong.
Learn more about why Novartis is taking India to court over the production of affordable generic medicines.
Novartis is taking India to court to stop production of affordable generic medicines that millions of people depend on to stay alive.
Learn how a free trade agreement between the European Union and India could restrict access to affordable medicines for millions of people with HIV/AIDS and other diseases and conditions.
This crisis could have been prevented but the major player involved, the Brazilian Ministry of Health, has shirked its responsibilities and is evidently unwilling to overcome the various challenges.
333 7th Avenue, New York, NY 10001-5004
A 501(c)(3) tax-exempt organization. Federal Identification Number (EIN): 13-3433452.